Intratumoral heterogeneity, reflected by the presence of a MET amplification in only one morphological region of the tumor but not the other, poses an additional challenge in assessing whether a given genetic alteration reflects an essential pathway that can serve as a molecular target. This evidence concerns the gene MET and neoplasm.